Hakutulokset - Ip, Michael

Intravitreal triamcinolone for management of idiopathic juxtafoveolar telangiectasis Tekijä Nema, Nitin, Ip, Michael S.

Hae kokoteksti Hae kokoteksti Hae kokoteksti

Diabetic Macular Edema: Therapeutic Options Tekijä Kulkarni, Amol D., Ip, Michael S.

Hae kokoteksti Hae kokoteksti Hae kokoteksti

Need for a New Classification of Diabetic Retinopathy Tekijä Jampol, Lee M., Tadayoni, Ramin, Ip, Michael

Hae kokoteksti Hae kokoteksti Hae kokoteksti

The Risk of Endophthalmitis Following Intravitreal Triamcinolone Injection in the DRCRnet and SCORE Clinical Trials Tekijä Bhavsar, Abdhish R., Ip, Michael S., Glassman, Adam R.

Hae kokoteksti Hae kokoteksti Hae kokoteksti

SCORE Study Report 8: Closed Tests for All Pair-Wise Comparisons of Means Tekijä Oden, Neal, VanVeldhuisen, Paul C., Scott, Ingrid U., Ip, Michael S.

Hae kokoteksti Hae kokoteksti

Attenuation of Choroidal Neovascularization by β2-Adrenergic Receptor Antagonism Tekijä Lavine, Jeremy A., Sang, Yanzhi, Wang, Shoujian, Ip, Michael S., Sheibani, Nader

Hae kokoteksti Hae kokoteksti Hae kokoteksti

Choriocapillaris flow impairment surrounding geographic atrophy correlates with disease progression Tekijä Nassisi, Marco, Baghdasaryan, Elmira, Borrelli, Enrico, Ip, Michael, Sadda, Srinivas R.

Hae kokoteksti Hae kokoteksti Hae kokoteksti

Alcohol Availability Across Neighborhoods in Ontario Following Alcohol Sales Deregulation, 2013–2017 Tekijä Myran, Daniel T., Chen, Jarvis T., Bearnot, Benjamin, Ip, Michael, Giesbrecht, Norman, Rees, Vaughan W.

Hae kokoteksti Hae kokoteksti Hae kokoteksti

Post hoc analysis of ellipsoid zone changes beyond the central subfield in symptomatic vitreomacular adhesion patients from the OASIS trial Tekijä Velaga, Swetha Bindu, Nittala, Muneeswar Gupta, Ip, Michael S, Duchateau, Luc, Sadda, SriniVas R

Hae kokoteksti Hae kokoteksti Hae kokoteksti

Baseline Characteristics and Outcomes After Anti–Vascular Endothelial Growth Factor Therapy for Macular Edema in Participants With Hemiretinal Vein Occlusion Compared With Particip... Tekijä Scott, Ingrid U., Oden, Neal L., VanVeldhuisen, Paul C., Ip, Michael S., Blodi, Barbara A.

Hae kokoteksti Hae kokoteksti Hae kokoteksti

SCORE2 Report 7. Long-term Physical Stability, Sterility and Anti-VEGF Bio-Activity of Repackaged Bevacizumab in 2 mL Glass Vials Tekijä Peterson, Jan S., Rockwell, Kenneth, Scott, Ingrid U., Ip, Michael S., VanVeldhuisen, Paul C., Blodi, Barbara A.

Hae kokoteksti Hae kokoteksti Hae kokoteksti

SCORE2 Report 1: Techniques to Optimize Recruitment in Phase III Clinical Trials of Patients with Central Retinal Vein Occlusion Tekijä Scott, Ingrid U., VanVeldhuisen, Paul C., Ip, Michael S., Blodi, Barbara A., Oden, Neal L., Figueroa, Maria

Hae kokoteksti Hae kokoteksti Hae kokoteksti

SCORE STUDY REPORT 12: Development of Venous Collaterals in the Score Study Tekijä WEINBERG, DAVID V., WAHLE, AIMEE E., IP, MICHAEL S., SCOTT, INGRID U., VANVELDHUISEN, PAUL C., BLODI, BARBARA A.

Hae kokoteksti Hae kokoteksti Hae kokoteksti

SCORE Study Report 7: Incidence of Intravitreal Silicone Oil Droplets Associated With Staked-on Versus Luer Cone Syringe Design Tekijä Scott, Ingrid U., Oden, Neal L., VanVeldhuisen, Paul C., Ip, Michael S., Blodi, Barbara A., Antoszyk, Andrew N.

Hae kokoteksti Hae kokoteksti Hae kokoteksti

SCORE2 Report 5: Vision-Related Function in Patients with Macular Edema Secondary to Central Retinal or Hemiretinal Vein Occlusion Tekijä Scott, Ingrid U., Figueroa, Maria J., Oden, Neal L., Ip, Michael S., Blodi, Barbara A., VanVeldhuisen, Paul C.

Hae kokoteksti Hae kokoteksti Hae kokoteksti

SCORE Study Report 15: Incidence, Risk Factors, and Timing of Elevated Intraocular Pressure after Intravitreal Triamcinolone Acetonide Injection for Macular Edema Secondary to Reti... Tekijä Aref, Ahmad A., Scott, Ingrid U., Oden, Neal L., Ip, Michael S., Blodi, Barbara A., VanVeldhuisen, Paul C.

Hae kokoteksti Hae kokoteksti Hae kokoteksti

Month 24 Outcomes After Treatment Initiation With Anti–Vascular Endothelial Growth Factor Therapy for Macular Edema Due to Central Retinal or Hemiretinal Vein Occlusion: SCORE2 Rep... Tekijä Scott, Ingrid U., Oden, Neal L., VanVeldhuisen, Paul C., Ip, Michael S., Blodi, Barbara A., Chan, Clement K.

Hae kokoteksti Hae kokoteksti Hae kokoteksti

Spectral Domain Optical Coherence Tomography Predictors of Visual Acuity in the Study of COmparative Treatments for REtinal Vein Occlusion 2 (SCORE2 Report 15) Tekijä Etheridge, Tyler, Blodi, Barbara, Oden, Neal, Van Veldhuisen, Paul, Scott, Ingrid U., Ip, Michael S., Mititelu, Mihai, Domalpally, Amitha

Hae kokoteksti Hae kokoteksti Hae kokoteksti

Association Between Early and Late Response in Eyes with Central or Hemiretinal Vein Occlusion Treated with Anti-VEGF Agents: SCORE2 Report 14: Secondary Analysis of the SCORE2 Cli... Tekijä Khurana, Rahul N., Oden, Neal L., VanVeldhuisen, Paul C., Scott, Ingrid U., Blodi, Barbara A., Ip, Michael S.

Hae kokoteksti Hae kokoteksti Hae kokoteksti

A Randomized Trial Comparing Intravitreal Triamcinolone and Focal/Grid Photocoagulation for Diabetic Macular Edema: Baseline Features Tekijä Ip, Michael S., Bressler, Susan B., Antoszyk, Andrew N., Flaxel, Christina J., Kim, Judy E., Friedman, Scott M., Qin, Haijing

Hae kokoteksti Hae kokoteksti Hae kokoteksti